相似文献
1
Effect of public corruption on the COVID-19 immunization progress.
Sci Rep. 2021 Dec 6;11(1):23423. doi: 10.1038/s41598-021-02802-1.
2
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
3
In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine.
Molecules. 2021 Oct 13;26(20):6182. doi: 10.3390/molecules26206182.
4
COVID-19 vaccines and vaccination program for aging adults.
Eur Rev Med Pharmacol Sci. 2021 Nov;25(21):6719-6730. doi: 10.26355/eurrev_202111_27117.
5
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.
6
Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
J Med Internet Res. 2021 Jan 15;23(1):e26089. doi: 10.2196/26089.
7
SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit.
Pediatr Blood Cancer. 2021 Oct;68(10):e29240. doi: 10.1002/pbc.29240. Epub 2021 Jul 15.
8
COVID-19 vaccination in Ukraine.
Lancet Infect Dis. 2021 Apr;21(4):462. doi: 10.1016/S1473-3099(21)00156-0.
9
Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities.
Proc Natl Acad Sci U S A. 2021 Sep 21;118(38). doi: 10.1073/pnas.2026382118.
10
COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program - Kentucky, March 2021.
MMWR Morb Mortal Wkly Rep. 2021 Apr 30;70(17):639-643. doi: 10.15585/mmwr.mm7017e2.
引用本文的文献
1
Corruption risks in COVID-19 vaccine deployment: lessons learned for future pandemic preparedness.
Global Health. 2025 Mar 7;21(1):8. doi: 10.1186/s12992-025-01096-6.
2
Determinants of COVID-19 vaccination coverage in European and Organisation for Economic Co-operation and Development (OECD) countries.
Front Public Health. 2024 Dec 31;12:1466858. doi: 10.3389/fpubh.2024.1466858. eCollection 2024.
3
Untangling the corruption maze: exploring the complexity of corruption in the health sector.
Health Econ Rev. 2024 Jul 12;14(1):50. doi: 10.1186/s13561-024-00530-6.
4
Multilevel analysis of COVID-19 vaccination intention: the moderating role of economic and cultural country characteristics.
Eur J Public Health. 2024 Apr 3;34(2):380-386. doi: 10.1093/eurpub/ckae022.
5
Acceptance of COVID-19 vaccine booster dose among the people of Bangladesh: A cross-sectional study.
Heliyon. 2023 Nov 11;9(11):e22215. doi: 10.1016/j.heliyon.2023.e22215. eCollection 2023 Nov.
6
COVID-19 Vaccination Coverage and Factors Influencing Vaccine Hesitancy among Patients with Inborn Errors of Immunity in Latvia: A Mixed-Methods Study.
Vaccines (Basel). 2023 Oct 25;11(11):1637. doi: 10.3390/vaccines11111637.
7
Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria.
J Pharm Policy Pract. 2023 Nov 13;16(1):141. doi: 10.1186/s40545-023-00649-7.
8
Quality and equity: a shared agenda for universal health coverage.
BMJ Glob Health. 2023 Jul;8(7). doi: 10.1136/bmjgh-2023-012561.
9
COVID-19 vaccination and governance in the case of low, middle and high-income countries.
BMC Public Health. 2023 Jun 5;23(1):1073. doi: 10.1186/s12889-023-15975-3.
10
Institutional quality and COVID-19 vaccination: does decentralization matter?
Lett Spat Resour Sci. 2023;16(1):6. doi: 10.1007/s12076-023-00326-y. Epub 2023 Feb 25.
本文引用的文献
1
COVID-19 fatalities and internal conflict: Does government economic support matter?
Eur J Polit Econ. 2023 Jun;78:102368. doi: 10.1016/j.ejpoleco.2023.102368. Epub 2023 Feb 24.
2
Employing medical anthropology approach as an additional public health strategy in promoting COVID-19 vaccine acceptance in Bhutan.
Int J Health Plann Manage. 2021 Sep;36(5):1943-1946. doi: 10.1002/hpm.3191. Epub 2021 May 12.
3
COVID-19 vaccine rollout-scale and speed carry different implications for corruption.
J Policy Model. 2021 May-Jun;43(3):503-520. doi: 10.1016/j.jpolmod.2021.04.003. Epub 2021 May 4.
4
A global survey of potential acceptance of a COVID-19 vaccine.
Nat Med. 2021 Feb;27(2):225-228. doi: 10.1038/s41591-020-1124-9. Epub 2020 Oct 20.
5
The Economic Cost of COVID Lockdowns: An Out-of-Equilibrium Analysis.
Econ Disaster Clim Chang. 2020;4(3):431-451. doi: 10.1007/s41885-020-00066-z. Epub 2020 Jun 19.
6
Covid-19 mortality is negatively associated with test number and government effectiveness.
Sci Rep. 2020 Jul 24;10(1):12567. doi: 10.1038/s41598-020-68862-x.
7
Corruption and health outcomes within an economic and cultural framework.
Eur J Health Econ. 2020 Mar;21(2):195-207. doi: 10.1007/s10198-019-01120-8. Epub 2019 Oct 5.
8
Contextual generalized trust and immunization against the 2009 A(H1N1) pandemic in the American states: A multilevel approach.
SSM Popul Health. 2016 Sep 10;2:632-639. doi: 10.1016/j.ssmph.2016.08.004. eCollection 2016 Dec.
9
Determinants of trust in the flu vaccine for African Americans and Whites.
Soc Sci Med. 2017 Nov;193:70-79. doi: 10.1016/j.socscimed.2017.10.001. Epub 2017 Oct 4.
10
Corruption costs lives: evidence from a cross-country study.
Eur J Health Econ. 2018 Jan;19(1):153-165. doi: 10.1007/s10198-017-0872-z. Epub 2017 Feb 14.
Zotero 插件